Medical Management of Neck and Low Back Pain




Summary of Key Points





  • Acute low back pain is common and has an excellent short-term prognosis.



  • Psychosocial variables are superior to structural findings or discography as predictors of both long- and short-term disability.



  • Chronic low back pain in the absence of clear underlying structural pathology may be related to central pain processing abnormalities (“central sensitization”).



  • Serious causes of low back pain (i.e., cancer, infection, fracture, spondylitis) are uncommon (affecting less than 5% of patients with back pain).



  • Imaging is not indicated in patients with acute back pain in the absence of clinical red flags.



  • There is little evidence to suggest that long-term opioid therapy in patients with chronic back or neck pain improves quality of life or functional status.



  • Active exercise is the cornerstone of treatment for chronic back pain, but studies comparing different exercise programs are lacking.



  • Adjunctive therapies including acupuncture, manipulation, and massage may provide additional benefit to patients with chronic back pain.



  • Alternative analgesics, particularly antidepressants, which inhibit norepinephrine reuptake, may be useful in patients with chronic back pain.



  • In selected patients with severe functional impairment and chronic pain, referral for interdisciplinary rehabilitation and cognitive behavioral therapy is recommended.



Back pain is common and costly. It was the most frequent type of pain reported by U.S. respondents in the 2002 National Health Information Survey (NHIS), with more than one fourth of adults reporting an episode of low back pain lasting at least 1 day in the preceding 3 months. In the NHIS survey, neck pain ranked third, with 13.8% of persons reporting at least a 1-day episode. Back pain ranks in the top five reasons for visits to primary care physicians in the United States, accounting for about 15 million office visits per year. Up to 71% of the adult population may experience a significant episode of neck pain in their lifetimes. Approximately 2% of the U.S. workforce sustains a compensable back injury each year. The direct cost of health care attributed for low back pain exceeds $25 billion in the United States. The largest proportion of direct medical costs for back pain is spent on physical therapy (17%), followed by pharmacy (13%) and primary care physician visits (13%). When indirect costs are included (lost work days and productivity), the total costs exceed $100 billion annually.


An appreciation of the benign short-term prognosis of acute nonradicular low back pain is fundamental to the management of these patients. Most patients recover within 1 month and more than 90% of patients have returned to work by 3 months. However, about one fourth of patients have persistent symptoms at 3 months, and about 20% have substantial limitations of activity at 1 year. Clearly, an important objective of medical treatment should be to reduce the likelihood of progression from acute symptoms to chronic pain and functional impairment. The primary determinants of persistent disability at 12 months are psychosocial in nature. In fact, psychosocial variables have been shown to be superior to structural findings or discography as predictors of both long- and short-term disability, duration of symptoms, and health care visits for back pain. High levels of psychological distress, depressive mood, and somatization are well established as risk factors for transition from acute back pain to chronicity. Coping style, particularly “fear avoidance,” has been shown to portend a poor prognosis in patients with subacute low back pain. Failure to recognize these psychosocial issues in patients with low back pain will frustrate even the most well-conceived medical management strategy.




Etiology of Back and Neck Pain


The specific anatomic etiology of nonradicular spinal pain is often ambiguous. Up to 85% of patients have pain that cannot be assigned to a particular pain generator. “Abnormal” findings on plain radiographs, including spondylolysis, spondylolisthesis, facet joint degenerative changes, Schmorl nodes, and mild scoliosis, are common in asymptomatic persons. Radiography of the lumbar spine in patients with back pain of at least 6 weeks’ duration (mean, 10 weeks) has been shown to increase patient satisfaction without any improvement in functional outcome or severity of pain. The addition of lateral dynamic flexion-extension radiographs to the initial evaluation of patients with low back pain rarely provides information that alters clinical management, at the expense of significant additional cost and radiation exposure. Disc abnormalities are found on magnetic resonance imaging (MRI) in more than 50% of asymptomatic persons by age 40 years and include degenerative disc bulging and protrusions as well as Schmorl nodes. The lack of specificity of clinical symptoms and signs for the multiple potential sources of spinal pain—ligaments, facet joints, discs, paravertebral musculature—confounds the attempt to attribute symptoms to radiographic findings. In some patients previously categorized as having nonspecific pain, interventional diagnostic techniques, including discography, facet joint medial branch block or injection, and sacroiliac joint injection, may suggest a specific pathoanatomic etiology. However, these studies have high false-positive rates, particularly in patients with psychosocial issues, and fail to reliably predict the success of specific surgical or interventional treatments. Chronic low back pain, particularly in the absence of any underlying structural pathology, has been described as residing more in the central nervous system that the musculoskeletal system. This concept implies that an alteration in the central nervous system (CNS) occurs in some patients with back pain (central sensitization), resulting in abnormal activation of pain processing centers and persistent pain despite the absence or resolution of the inciting event.


Cancer and infection are serious but fortunately uncommon specific causes of back pain found in 0.7% and 0.01%, respectively, of patients presenting in a primary care setting. Ankylosing spondylitis is identified in about 0.3% of patients with low back pain, typically younger men. Acute or subacute vertebral compression fractures are identified in about 4% of patients. A variety of nonspinal conditions may present with symptoms that mimic spine disorders. These include common musculoskeletal problems such as greater trochanteric bursitis and osteoarthritis of the hip, as well as visceral problems such as kidney stones, aortic aneurysms, and peptic ulcers.


The American College of Physicians and American Pain Society’s evidence-based clinical practice guideline for the management of back pain suggests a focused history and physical examination should permit placement of patients with back pain into one of three broad categories: nonspecific low back pain, back pain with radicular symptoms including lumbar spinal stenosis, and back pain associated with another specific spinal cause. Diagnostic imaging is recommended only when a serious etiology (cancer or infection) is suspected or when surgical or other interventional treatment is imminent ( Box 106-1 ). For patients with nonspecific, nonradicular back pain, the guideline incorporates education, activity, physical therapy, medications, and a range of nonpharmacologic therapies.



Box 106-1

American College of Physicians and the American Pain Society

Recommendations for the Evaluation of Low Back Pain





  • Recommendation 1: Conduct a focused history and physical examination to assign patients into one of three categories: nonspecific low back pain, back pain potentially associated with radiculopathy or spinal stenosis, or back pain potentially associated with another specific spine cause. Evaluate for psychosocial risk factors that predict risk for chronic, disabling low back pain.



  • Recommendation 2: Imaging or other diagnostic tests should not be obtained routinely in patients with nonspecific low back pain.



  • Recommendation 3: Perform diagnostic imaging and testing for patients with low back pain when severe or progressive neurologic deficits are present or when serious underlying conditions are suspected on the basis of history and physical examination.



  • Recommendation 4: Evaluate patients with persistent low back pain and signs or symptoms of radiculopathy or stenosis with magnetic resonance imaging (MRI; preferred) or computed tomography (CT) only if they are potential candidates for surgery or epidural steroid injection.






Medical Treatment Options


Prevention


In view of the enormous personal, societal, and financial burden of back pain, numerous preventive approaches have been investigated. A systematic review of prospective, controlled trials of interventions to prevent back pain in working-age adults identified 20 trials that met inclusion criteria. Only exercise, in seven of eight trials, was found effective in preventing self-reported episodes of back pain. A variety of exercise approaches were used, including stretching; strengthening of abdominal, back, and leg muscles; and general conditioning. Interventions found ineffective in reducing back pain episodes included stress management, shoe inserts, back supports, ergonomic and back education, and reduced lifting programs. Although evidence for efficacy in prevention of back pain is lacking, smoking cessation and reduction to appropriate weight for height should be encouraged because both smoking and obesity have been associated with increased severity of back symptoms.


Exercise and Physical Therapy


For most patients with acute (< 4 weeks) back or neck pain, there is little evidence that formal physical therapy is necessary. The best advice for such patients is probably to continue with their usual activities as tolerated. In fact, early referral to physical therapy prolonged the duration of symptoms compared with patients simply advised to stay active. A self-administered instrument, the Keele STarT Back Screening tool, was developed and validated to stratify the intensity of initial treatment in patients with back pain in the primary care setting. The nine-item tool categorizes patients into three groups based on risk of long-term disability. Low-risk patients may be treated with a single education session. Patients categorized as medium risk require formal physical therapy referral, and high-risk patients are referred for “psychologically informed physical therapy.”


For most patients with persistent chronic neck or back symptoms, exercise therapy is the cornerstone of medical treatment to decrease pain and restore function and mobility. An impairment-based manual physical therapy and exercise program resulted in clinically and statistically significant short- and long-term improvements in pain, disability, and patient-perceived recovery in patients with mechanical neck pain compared with a program composed of advice, mobility exercise, and subtherapeutic ultrasonography. Similarly, one meta-analysis found that exercise therapy was effective at decreasing pain and improving function in adults with chronic low back pain and may reduce work absenteeism in patients with subacute symptoms. Unfortunately, studies comparing different exercise approaches, including stabilization, McKenzie, Pilates, and general aerobic conditioning, are insufficient to strongly recommend a single approach in a particular subset of patients. However, studies have suggested that selection of a physical therapy approach based on diagnosis or mechanical assessment is more effective than general nonspecific exercise advice.


General aerobic conditioning is often recommended for patients with chronic neck or back pain. The sense of well-being and accomplishment acquired from a planned aerobic exercise program such as walking, running, cycling, or swimming creates a positive treatment milieu and further establishes the extent of patient motivation and commitment to the overall treatment plan. Patients participating in an aerobic exercise program have been shown to receive fewer prescriptions for pain, were given fewer physical therapy referrals, and had improved mood states and lessened depression.


Evidence suggests the superiority of neck stabilization exercises, with some advantages in pain and disability outcomes, compared with isometric and stretching exercises in combination with physical therapy agents (transcutaneous electrical nerve stimulation, continuous ultrasonography, and infrared irradiation) for the management of neck pain. There is moderate evidence that lumbar stabilization exercises are effective in improving pain and function in a heterogeneous group of patients with chronic low back pain. Unfortunately, available studies are unable to define a specific subgroup of patients with chronic low back pain most suitable for this exercise approach. The current evidence suggests that in the short term, lumbar extensor strengthening exercise administered alone or with co-interventions is more effective than no treatment and most passive modalities in improving pain, disability, and other patient-reported outcomes in chronic low back pain.


Yoga and Pilates exercises have grown in popularity and represent two mind-body exercise interventions that address both the physical and mental aspects of pain with core strengthening, flexibility, and relaxation. There has been a gradual trend toward inclusion of these nontraditional exercise regimens into treatment paradigms for back pain, although few studies critically examining their effects have been published. Two systematic reviews of Pilates for low back pain concluded the evidence was inconclusive that Pilates is effective in reducing pain and disability in patients with low back pain. Evidence that yoga is beneficial for low back pain is more robust. These trials suggest that there is reasonably strong evidence that yoga is superior to usual care in chronic back pain in pain and general health measures, particularly at 6 months.


The McKenzie method is a unique and comprehensive approach to neck or low back pain that includes both assessment and intervention. The assessment is designed to detect a directional preference, which refers to a particular direction of movement or sustained posture that causes symptoms to centralize, decrease, or be abolished. Centralization is defined as the sequential and lasting abolition of all distal referred symptoms and subsequent abolition of any remaining spinal pain in response to a single direction of repeated movements or sustained postures. The finding of centralization has positive prognostic value, provided treatment is guided by assessment findings. Noncentralization is a strong predictor of poor prognosis and correlates well with “nonorganic” signs. In limited clinical trials, McKenzie-based therapy produces results comparable with those of stabilization or strengthening programs.


Aquatic exercise is potentially beneficial to patients suffering from chronic low back pain and pregnancy-related low back pain. Patients with barriers to land-based programs, including lower extremity joint disorders and obesity, are often able to exercise actively in the pool.


Medication


In addition to passage of time, participation in an active exercise program, and use of nonpharmacologic treatments, medicinal treatment is a common component of medical management of neck and back pain. Medications commonly used for low back pain include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, opioids, skeletal muscle relaxants (for acute low back pain), and antidepressants (for chronic low back pain).


Acetaminophen


Acetaminophen (acetyl-para-aminophenol [APAP]) has analgesic and antipyretic properties comparable with aspirin, but its anti-inflammatory effects are weak. APAP’s analgesic effects and excellent safety profile have established it as a reasonable first-line medication to suggest for acute back and neck pain, particularly in the elderly population. APAP is relatively inexpensive and produces fewer adverse reactions than NSAIDs. Although some systematic reviews have found APAP to be as effective as NSAIDs in the treatment of back pain, NSAIDS seem superior in efficacy in other musculoskeletal disorders, particularly osteoarthritis of the hip or knee. In addition, one study found regular or as-needed acetaminophen was no more effective than placebo in affecting recovery time in persons with acute low back pain. The accepted oral dose of acetaminophen is 325 to 1000 mg every 4 to 6 hours, not to exceed 4000 mg in 24 hours. The most serious adverse effect of acute acetaminophen overdosage is hepatotoxicity. Risk of hepatotoxicity is increased in patients with known liver disease, heavy alcohol use, or severe fasting states due to vomiting, diarrhea, or severe flu. A major current concern is accidental overdosage in patients who take APAP in addition to a prescription analgesic containing APAP. In adults, serious hepatotoxicity may occur from a single dose of 10 to 15 g.


Nonsteroidal Anti-inflammatory Drugs


The NSAIDs relieve both pain and inflammation and are a reasonable choice as a first-line agent for the control of acute low back or neck pain in patients without significant risk factors for adverse effects. A systematic review of randomized, controlled trials found NSAIDs were effective for short-term relief of acute and chronic back pain, but no more effective than acetaminophen. This review and others have concluded that all NSAIDs, including cyclooxygenase-2 (COX-2) inhibitors, are equally effective in treating low back pain. Because efficacy among these drugs is comparable, the choice of a particular NSAID is based on cost and safety, particularly in patients at higher risk for adverse effects. Gastrointestinal (GI) toxicity is the major limiting factor to NSAID therapy, with serious ulcer complications (bleeding or perforation) seen in about 1.5% of treated patients. All NSAIDs may increase the risk of a cardiovascular event in patients at risk. The American Heart Association recommendations for drug therapy for musculoskeletal pain in patients at cardiovascular risk favor pure analgesics as the drugs of first choice, with nonacetylated salicylates such as salsalate or non-COX-2–selective drugs (particularly naproxen) as alternative choices. Other potential side effects include renal failure, tinnitus, fluid retention, and high blood pressure. Although some variability with regard to adverse effects has been recognized, all NSAIDs can cause central nervous system side effects such as drowsiness, dizziness, and confusion. If an NSAID is used, regular clinical and laboratory monitoring for adverse renal or GI reactions is mandatory. Risk factors for NSAID toxicity include age older than 65 years, known or suspected cardiovascular disease, history of congestive heart failure, history of recent GI bleed or ulcer, kidney disease, hepatic cirrhosis, and history of aspirin-induced respiratory disease. NSAIDs should also be avoided in patients in the third trimester of pregnancy. Acetaminophen is relatively inexpensive with a superior safety profile to NSAIDs and is the first choice in such high-risk patients.


Oral Steroids


Medications such as prednisone and methylprednisolone are potent corticosteroids with strong anti-inflammatory properties. Corticosteroids are effective in the treatment of inflammatory reactions associated with allergic states, rheumatic and autoimmune diseases, and respiratory disorders. Studies designed to investigate the use of oral steroids in the setting of low back or neck pain are limited. A placebo-controlled trial of a single dose of intravenous methylprednisolone in acute low back pain demonstrated no significant improvement in the steroid-treated group. Despite the lack of any published evidence for efficacy, oral corticosteroids are widely prescribed to treat acute back or neck pain, particularly with radicular symptoms. Dosage schedules vary, but 7 to 14 days of tapering from a prednisone equivalent dose of 40 to 60 mg is typical. Patients with diabetes should be warned about steroid-induced hyperglycemia. The risk of steroid-induced osteonecrosis is a concern, but the risk appears low.


Antidepressant Medications


Antidepressants are often used in the treatment of chronic musculoskeletal pain as well as in neuropathic pain syndromes. Although there is no evidence to support their use in acute pain, the efficacy of antidepressants in patients with chronic low back pain is reasonably well established. Antidepressant drug therapy may be beneficial in these patients because up to one third of them also experience depression. However, treating nondepressed patients with tricyclic antidepressants has been shown to significantly improve neuropathic-type pain compared with placebo, but without an improvement in functional status. In contrast to tricyclic antidepressants, newer selective serotonin reuptake inhibitors have not been demonstrated to be effective in treating back or neck pain.


Opioids


Opioids represent the most commonly prescribed class of drug for spinal pain with a more than 600% increase in expenditure for this treatment for spine problems from 1997 to 2006. Up to two thirds of patients seen in clinical practice for back pain receive opioids, 25% for longer than 3 months. Despite an increasing and widespread use, however, evidence of opioid efficacy in both acute and chronic back pain is limited. Concern about adverse effect on clinical outcomes and risk of abuse, tolerance, dependence, and death-related to overdose is growing. In acute low back pain, no randomized controlled trials comparing opioids with placebo were identified in a systematic review. In work-related back pain patients, those prescribed an opioid within the first 2 weeks had a greater risk of long-term disability. In acute low back pain, studies comparing opioid therapy with acetaminophen and NSAIDs are lacking. Systematic reviews of opioid therapy in chronic low back pain demonstrate better analgesic efficacy than placebo, but benefits for function are inconsistent. These studies are typically short term (less than 6 months) with high dropout rates. For chronic noncancer pain, the magnitude of pain relief with opioid therapy is about 30%. Patients with chronic noncancer pain treated with opioids have worse quality of life and function than those not taking opioids.


Although most opioids share common pharmacologic properties and mechanisms of action, unique properties of selected agents are clinically relevant. Methadone is an effective and relatively inexpensive long-acting opioid analgesic with unique pharmacokinetics and mechanism of action. In addition to activity at the mu-opioid receptor like other agents, methadone inhibits serotonin uptake and antagonizes the N -methyl- d -aspartate (NMDA) receptor, potentially offering superior efficacy for neuropathic pain. However, because of a disparity between duration of analgesic effect (8 hours) and drug half-life (24 to 26 hours), initiating treatment with methadone must be done cautiously, with increments in the dose at 5- to 7-day intervals. Tramadol and its active metabolite exert their analgesic effect as both mu receptor agonists and by nonopioid inhibition of serotonin and norepinephrine reuptake. Co-administration of tramadol with antidepressants of the selective serotonin reuptake inhibitor class risks development of a “serotonin syndrome” manifested by hyperactivity, agitation, fever, seizures, and even death. Finally, meperidine has a half-life of 3 hours, but the half-life of its inactive metabolite normeperidine is about 20 hours. Repeated administration of meperidine for pain relief may result in toxic levels of normeperidine, particularly in elderly patients. Clinical manifestations of normeperidine toxicity include tremors, hallucinations, and seizures.


In most studies approximately one third of opioid-treated patients withdraw because of intolerable adverse effects. Constipation is the most common adverse effect of opioid therapy and does not improve with time. Sedation is seen in almost one third of opioid-treated patients and may increase the risk of falls. It is also a concern in patients who drive. Whether opioids increase the risk of motor vehicle accidents has been controversial. A systematic review found no impairment of psychomotor abilities of opioid-dependent patients. However, risk of motor vehicle accidents is increased in opioid treated patients. Unlike other analgesics, including acetaminophen or NSAIDs, opioids are not toxic to the liver, kidneys, brain, or other organs. In men, androgen deficiency manifested by low libido, erectile dysfunction, and lack of energy is a concern because opioids suppress gonadotropin-releasing hormone. Whether long-term opioid therapy with gonadotropin-releasing hormone suppression results in bone loss (“opioid osteoporosis”) is uncertain.


Tolerance, the need to increase opioid dosage to maintain the same therapeutic effect, appears to be uncommon in patients with low back pain treated with opioids. Most opioid-treated patients become dependent within a few weeks of initiating treatment. Addiction, on the other hand, represents a maladaptive disorder characterized by compulsive use of an opioid despite biologic, psychological, or social harm. In the absence of a prior history of substance abuse, the risk of addiction in opioid-treated patients with low back pain appears low. However, with increasing opioid use, deaths related to opioid overdose now exceed 16,000 per year in the United States, greater than those due to heroin or cocaine. Risk of overdose is compounded in patients receiving concurrent benzodiazepine therapy. When opioid therapy is considered in patients with chronic spinal pain, a careful assessment of risk for abuse, misuse, or diversion should be performed. This assessment should include evaluation for known risk factors, including smoking, psychiatric disorders, and personal history or family history of substance abuse. In patients on long-term opioid therapy, risk management for abuse should include use of a prescription monitoring program as is available in most states; an opioid treatment agreement outlining risk, benefits, and behavior expectations to the patient beginning therapy; and compliance monitoring with urine drug screens. Short-term follow-up, usually within 1 month, is required to assess both pain and functional improvement. If insufficient, the drug should be withdrawn.


Muscle Relaxants


Muscle relaxants are widely used to treat low back and neck pain, presumably to address muscle spasm as the primary source of spinal pain or as a secondary phenomenon superimposed on underlying spine pathology. These drugs, which include benzodiazepine and nonbenzodiazepine antispasmodics and antispasticity agents, are believed to act centrally at the brain stem or spinal cord level. Systematic reviews of muscle relaxants for nonspecific low back pain have concluded that all are comparably effective in providing early, short-term pain relief compared with placebo, but with significant risk of side effects. In acute back pain, the treatment benefit appears greatest in the first few days and declines rapidly after the first week of symptoms. There is limited evidence that combination of an NSAID and a muscle relaxant is modestly more effective than either agent alone. No studies have demonstrated benefit of muscle relaxants in chronic low back pain.


Approximately 50% of persons treated with muscle relaxants experience an adverse effect, most commonly dizziness and sedation. Benzodiazepines, cyclobenzaprine, and tizanidine tend to be more sedating than metaxalone or methocarbamol. However, alertness and cognitive acuity may be impaired by any muscle relaxant. Carisoprodol is metabolized to meprobamate, a highly addictive barbiturate. Because carisoprodol is not more effective than alternative muscle relaxants, it should be avoided. Cyclobenzaprine is chemically in the same class as tricyclic antidepressants and should not be used in patients with significant cardiac arrhythmias.


The selection of a muscle relaxant is based primarily on the risk of adverse effects, abuse potential, and drug interactions because efficacy is comparable for all of the agents. In patients with insomnia or disrupted sleep, a sedating agent such as cyclobenzaprine or tizanidine may be preferable. For patients intolerant of sedative effects, a trial of metaxalone or methocarbamol is appropriate.


Anticonvulsants, Antiepileptics, and Membrane Stabilizers


There is limited evidence directly evaluating the efficacy of antiepileptic medications for chronic low back, radicular, or neuropathic pain. However, use of these medications may be reasonable for patients with persistent back or neck pain despite treatment with simple analgesics, NSAIDs, or tricyclic antidepressants. Gabapentin has U.S. Food and Drug Administration (FDA)–approved labeling for trigeminal neuralgia, but it is widely used to treat neuropathic pain of other sources. Dose-related sedation is a limiting factor with gabapentin. Pregabalin is one of the newer membrane stabilizers used in painful neuropathic and musculoskeletal conditions, including fibromyalgia. Carbamazepine is an older anticonvulsant that has FDA-approved labeling for trigeminal neuralgia and is sometimes used for other types of neuropathic pain. Oxcarbamazepine, topiramate, lamotrigine, tiagabine, and valproate have been reported in case studies to offer relief from neuropathic discomfort. These agents are typically used at their anticonvulsant dosages. Antiepileptic drugs act at several sites that may be relevant to pain, but the precise mechanism of their analgesic effect remains unclear. They may limit neuronal excitation and enhance inhibition. Transmission of painful stimuli through the spinal column and central nervous system is modulated by excitatory and inhibitory neurotransmitters, as well as actions at sodium and calcium channels. Antidepressants and antiepileptic drugs are also thought to diminish neuropathic pain through interaction with specific neurotransmitters and ion channels.


Topicals


Topical pain-relieving medications are preparations applied to the skin as a cream, ointment, gel, patch, or spray. Although widely used by patients with spinal pain, evidence of significant benefit for pain and function is minimal. Common types of topical pain relievers include local anesthetics, analgesics, and anti-inflammatories, including salicylates. Another readily available, somewhat unusual, and widely used topical medication is capsaicin, which is derived from hot peppers. Capsaicin’s therapeutic effect is attributed to reduction of the pain neurotransmitter, substance P.


Acupuncture


Acupuncture is based on Chinese traditions and concepts dating to more than 2000 years ago. Illness in classical Chinese medicine is defined by disharmony or imbalance in yin and yang , with resultant disruption in the flow of qi in the various meridians or channels through which it flows. In this paradigm, treatment requires insertion of needles in specific points to influence movement of qi , tonify deficient yin or yang , or disperse excess yang. As acupuncture has become established in the West, studies investigating its physiologic effects have demonstrated multiple potential explanations for an analgesic effect.


Acupuncture has been increasingly accepted as a useful modality in the treatment of back and neck pain. Approximately two thirds of pain specialists and rheumatologists report referrals to practitioners of acupuncture. A National Institutes of Health consensus conference in 1998 concluded that acupuncture might be useful as an adjunct treatment for low back pain or an acceptable alternative to be included in a comprehensive management program. Ten years later, the American College of Physicians and American Pain Society guideline on the diagnosis and treatment of low back pain recommended that acupuncture be considered as a nonpharmacologic treatment with proved benefits for patients with chronic or subacute, nonspecific low back pain. A systematic review of the effectiveness of acupuncture for back pain found 23 randomized, controlled trials including more than 6000 patients. This analysis concluded that there is moderate evidence that acupuncture is more effective than no treatment and strong evidence of no significant difference between acupuncture and sham acupuncture for short-term pain relief. The authors also concluded that there is strong evidence that acupuncture can be a useful supplement to other forms of conventional treatment for nonspecific low back pain.


A reasonable trial of acupuncture in most patients requires 6 to 10 treatments, perhaps more in older patients. Acupuncture is contraindicated in patients with severe bleeding disorders or systemic infection. Electroacupuncture should be avoided in patients with pacemakers, defibrillators, implanted medication pumps, and implanted neuromodulating devices. In pregnant patients, acupuncture points that may stimulate labor are “forbidden.” Opioid-dependent patients may be less responsive to acupuncture. Serious complications of acupuncture such as organ or vascular puncture are extremely rare.


Manipulation


Spinal manipulation is defined as the application of high-velocity, low-amplitude manual thrusts to the spinal joints with movement beyond the passive range of motion. Chiropractors perform more than 90% of all manipulations in the United States, but other practitioners include osteopathic physicians and physical therapists. Almost 90% of visits to chiropractors are for neck or back pain.


Manipulation techniques vary considerably based on the training of the practitioner. In general, osteopathic manipulation uses a long-lever, lower-velocity technique using a long bone such as the femur to apply force to one or more joints. Short-lever, higher-velocity manipulation of a specific joint represents the more commonly performed chiropractic spinal “adjustment.” More recently, medicine-assisted manipulation has been reintroduced, primarily in the chiropractic community. This technique involves spinal manipulation after local anesthesia (epidural or facet) or with deep conscious sedation. To date, medicine-assisted manipulation has not been evaluated in a controlled trial.


The precise mechanism of action for any effects attributed to manipulation remains unknown. Current hypotheses focus on either direct effects on the facet joints themselves or secondary neurologic effects of facet and myofascial manipulation. Manipulation may release trapped synovial plica, alter orientation of the joint, relax periarticular hypertonic muscles, disrupt adhesions, or unbuckle abnormal motion segments. There is some evidence that manipulation may affect afferent nerves in the paraspinal musculature, inhibiting excessive reflex activity and potentially affecting central pain processing.


For patients with acute or subacute low back pain, manipulation has been shown to be superior to sham manipulation but not statistically or clinically superior to general care, analgesics, physical therapy, exercises, or back schools. In a randomized clinical trial, patients with acute and subacute back pain treated with osteopathic manipulation required significantly less medication than the standard care group, however. In another large, prospective, randomized trial comparing chiropractic manipulation with medical care, including physical therapy, similar outcomes were noted in pain and disability, but patients treated with manipulation had a greater likelihood of perceived improvement. For mechanical neck pain, manipulation in addition to exercise was found superior to waiting list controls for pain reduction in a systematic review of 33 trials.


Mild adverse effects of spinal manipulation occur in 30% to 61% of all patients. Most of these effects occur within 4 hours of treatment and resolve the same day. The most common symptoms reported include local discomfort (53%), headache (12%), tiredness (11%), radiating discomfort (10%), and dizziness (5%). Serious adverse affects of lumbar manipulation such as disc herniation or cauda equina syndrome are rare, estimated at 1 event per 3.72 million manipulations. Risk of serious injury from cervical manipulation, particularly vertebral artery dissection, is well described, but the frequency is unknown. Although likely rare, the consequences of this complication are potentially catastrophic, such that some have suggested avoidance of cervical manipulation in patients with known atherosclerotic cardiovascular disease.


Massage


Massage, defined as manipulation of muscle and fascia using one’s hands or a mechanical device, is a widely used adjunctive treatment in patients with neck and back pain. Common variations of massage include rolfing, Swedish massage, acupuncture massage, myofascial release, and craniosacral therapy. Therapeutic benefits of massage have been attributed to local effects, including increased blood flow and oxygenation of tissues and relaxation of tight muscles. Other proposed mechanisms include stimulation of serotonin or endorphin release, as well as effects on pain transmission at the spinal segmental level.


Systematic reviews of massage therapy have concluded that massage is effective for subacute and chronic low back pain. Although limited in number and mixed in quality, clinical trials have shown massage is more effective than exercise, acupuncture, and self-care education in improving symptoms and function in patients with nonspecific low back pain. Several trials have suggested that the addition of massage to exercise improves outcome in patients with low back pain compared with exercise alone. These studies also suggest that the experience of the massage therapist influences outcome. The optimal number and frequency of treatments are not known.


Studies of massage for chronic neck pain are less definitive. A review of 19 trials of massage for “mechanical” neck pain found 12 were of low quality. The remaining studies of massage for neck pain as a stand-alone treatment or as part of a multimodality treatment approach were inconclusive.


Traction


Theoretically, the objective of spinal traction is to distract the vertebrae, potentially reducing protrusion of a bulging or herniated disc. Approximately 1.5 times a patient’s body weight is needed to develop distraction of the vertebral bodies. This is rarely achieved in clinical practice because patient tolerance is poor. No specific effect of traction over standard physiotherapeutic interventions was observed in adults with chronic neck pain. Conceptually, traction may be useful as an adjunct to active exercise therapy to assist in releasing muscle spasm and facilitating active therapy, but evidence for benefit is lacking. The current literature does not support or refute the effectiveness of continuous or intermittent traction for pain reduction, improved function, or global perceived effect compared with placebo traction, tablet or heat, or other conservative treatments in patients with chronic neck disorders. Only limited evidence is available to warrant the routine use of nonsurgical spinal decompression, particularly when many other well-investigated, less expensive alternatives are available.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 12, 2019 | Posted by in NEUROSURGERY | Comments Off on Medical Management of Neck and Low Back Pain

Full access? Get Clinical Tree

Get Clinical Tree app for offline access